| 2.2 |
6.5 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 1.4 |
7.1 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 1.0 |
10.5 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.7 |
2.9 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.4 |
2.2 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.3 |
1.0 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.3 |
1.0 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.3 |
2.1 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.3 |
1.4 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.3 |
2.7 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.2 |
1.4 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.2 |
1.1 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.2 |
2.2 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.2 |
0.8 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.2 |
0.6 |
GO:0008228 |
opsonization(GO:0008228) modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.2 |
0.8 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.2 |
0.9 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.2 |
0.3 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.2 |
0.5 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.1 |
0.4 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.1 |
2.9 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.1 |
0.9 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
1.4 |
GO:1901629 |
regulation of presynaptic membrane organization(GO:1901629) |
| 0.1 |
0.6 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.1 |
0.3 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.1 |
0.4 |
GO:2001137 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) positive regulation of endocytic recycling(GO:2001137) |
| 0.1 |
0.4 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
2.0 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.1 |
0.4 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.1 |
0.3 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
0.5 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.1 |
0.3 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.1 |
0.2 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) Tie signaling pathway(GO:0048014) |
| 0.1 |
0.2 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 |
1.4 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.1 |
1.8 |
GO:0071398 |
cellular response to fatty acid(GO:0071398) |
| 0.1 |
2.2 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.1 |
0.2 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
0.9 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.1 |
0.6 |
GO:0036120 |
cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.0 |
0.5 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.0 |
0.5 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 |
0.2 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.0 |
1.4 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
0.6 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.0 |
0.8 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.0 |
0.3 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.3 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 |
0.2 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.0 |
0.3 |
GO:0002674 |
negative regulation of acute inflammatory response(GO:0002674) |
| 0.0 |
0.3 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.0 |
0.1 |
GO:0060745 |
mammary gland branching involved in pregnancy(GO:0060745) |
| 0.0 |
0.2 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.0 |
0.1 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.0 |
1.1 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.5 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.2 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.0 |
0.0 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.0 |
0.2 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.0 |
0.6 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.0 |
0.4 |
GO:0001508 |
action potential(GO:0001508) |
| 0.0 |
0.1 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.0 |
0.2 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.0 |
0.2 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
0.1 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.0 |
0.1 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.0 |
0.2 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.0 |
0.1 |
GO:0035878 |
nail development(GO:0035878) |
| 0.0 |
0.5 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.2 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) regulation of high voltage-gated calcium channel activity(GO:1901841) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 |
0.2 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.0 |
8.7 |
GO:0006397 |
mRNA processing(GO:0006397) |
| 0.0 |
1.8 |
GO:0045814 |
negative regulation of gene expression, epigenetic(GO:0045814) |
| 0.0 |
0.1 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.2 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
1.3 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
0.7 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.0 |
0.6 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.0 |
0.2 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.0 |
0.1 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.2 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.0 |
0.5 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.1 |
GO:2001014 |
regulation of myoblast proliferation(GO:2000291) regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.0 |
0.5 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
